This website is for educational purposes only and does not constitute investment advice. Always do your own research and assess your own risk tolerance before making investment decisions.

US End-of-Day Verdict 31 Aug 2026, 16:00:00 GMT-4

Sector ETFs — End-of-Day Verdict

EOD 2026-09-01 (sectoretf)

Recommendations

1 to acquire · 0 to dispose

TickerNameCloseActionAction Price Where to act — a buy-limit on a pullback or a buy-stop above resistance, not the current price. Sanity-check vs Close: on a held name, an action price stranded above the close means the queued level was set when the stock was higher — stale, awaiting reprice. Stop The risk-defined exit, set below the entry for a long (~1.2–1.8×ATR). A held long whose Stop sits at/above the Close is already below its stop — a stale box awaiting reprice. 1wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close. 4wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close. 12wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close. Rationale
XLEEnergy Select Sector SPDR64.77BUY64.7261.0764.77 (+0.1%)65.83 (+1.7%)68.18 (+5.3%)Energy is the one sector with a live bid and a hard catalyst behind it: US Central Command struck Iranian targets and two tankers were hit leaving the Strait of Hormuz, pushing Brent above and XLE closed +1.27% at a fresh 52-week high on a day the S&P fell 0.7% and the Nasdaq 1.4%. That is relative strength earned against the tape, not with it, and the fund carries the board's only Trending regime with a fully stacked EMA ladder. We are buying the supply shock with a genuinely wide stop rather than a cosmetic one. OPS: STRONG BUY cv78 (adj 78), Buy_Rank 1, second consecutive STRONG BUY print. Buy-stop sits BELOW the close so it is immediately marketable at the open; entry range - (Entry +/- 0.25 ATR). Sizing: 85.49% x x 20% =, capped by 60% max_position_pct applied to DECLARED capital = (cap BINDING) -> =; reserve retained into 09-04 payrolls. Stop is a real 3.11 ATR / -5.64%; risk 463 x = = 3.38% of book -- the largest single-position risk this book has proposed, stated deliberately. WEAKNESSES, NOT SMOOTHED OVER: (a) Est_4W payoff is only 0.30x on the (Est_4W-Entry)/(Entry-Stop) convention -- the model sees just +1.7% of four-week upside against a 5.6% stop; (b) RSI 70.5 and 0.28% off the 52-week high; (c) this is the same name whose GTC was withdrawn unfilled on 08-28 at -- we are re-entering 3.3% higher, and that withdrawal cost 5.97% measured to today; (d) GAP RISK IS ASYMMETRIC -- a Hormuz de-escalation headline can gap through a 5.6% stop overnight, which no stop protects against. Taken because the driver is current and physical rather than narrative, because BreakoutUp_20D is report-only in this book (n=2, no bias applied) rather than the discounted FailedBreakdown family, and because the no_chase_queue counterfactual reads [cost] at median +2.23%/1wk -- withholding has been this book's more expensive error. SE-2 does NOT fire: Est_12W > Est_4W > close, non-inverted. SE-3 flag: calib_1w = -0.08, the 1wk print (, +0.08%) is low-reliability; the f=0.30 fallback gives (+3.39%) instead -- a wide divergence, so do not lean on either. L6 does not fire (no earnings gap). L8: executes at the 2026-09-02 open; reprice if it gaps >1.5%. · news
First Trust Cloud Computing ETFNO ACTIONn/an/an/aDeclined on a news override, and it was the closest call of the day. The pre-registered 08-28 re-arm fired on all three legs -- close inside the -162 band, conviction 73 >= 69, stop widened to 1.16 ATR > 1.0 -- and PullbackBuy_VWAP is the L1-favoured family and this book's only non-negative actionable cell (bias +0). What kills it is that the pullback has a named, live, ongoing cause rather than being noise: the 10-year Treasury yield hit a one-year high of 4.8% and SKYY fell 2% against QQQ's 1%, precisely because debt-heavy cloud and AI-infrastructure names absorb rate shocks hardest (Oracle -4%, Nebius -3% the same session). A mean-reversion entry into an active repricing is buying the mechanism, not against it -- and there are two more scheduled amplifiers inside seven sessions (09-04 payrolls, 09-11 CPI, both high confidence). It also carries the weakest forward expectancy of the four floor-clearing candidates: +0.50 ATR at 4wk, +1.53 ATR at 12wk, and the cell's hit_4w is 0.167 (n=10) -- it reaches 1wk targets half the time but rarely holds. RE-ARM: take it once the 10-year stops making new highs or after the 09-04 payrolls print resolves, with conviction still >=69 and price holding above EMA20 -- or on any session where SKYY outperforms QQQ on a red tape.
SPDR S&P Biotech ETFNO ACTIONn/an/an/aDeclined on stop geometry despite the board's best forward expectancy. XBI closed +0.55% green on a rate-shocked red tape, prints the best four-week read on the board (+1.42 ATR, Est_4W = +3.9%) and a non-inverted +7.3% twelve-week leg, and biotech's 2026 driver -- decade-high M&A volume, clinical data, clearer policy risk -- is the least yield-sensitive story in the growth complex. The disqualifier is the stop: is exactly 0.50 ATR, the hardcoded FailedBreakdown family constant, i.e. a 1.37% stop on a fund whose daily ATR is 2.74%. Its headline 2.83x Est_4W payoff is manufactured entirely by that undersized denominator, and this book's own record confirms the cost: FailedBreakdown_Up_20D|buy is n=14, hit_1w 0.385, hit_4w 0.30, historic stop_first ~0.667 (SE-1, live bias -2). It is also a single-print flip out of three consecutive NO TRADE cv0 prints -- no stability behind it. Paying to be stopped out on noise is not a trade at any size. RE-ARM: take it on a print where the stop widens past 1.0 ATR, or on a SECOND consecutive BUY print with conviction >= above EMA20.
iShares Biotechnology ETFNO ACTIONn/an/an/aDeclined on a dead four-week leg -- the same biotech tailwind as XBI but none of the payoff. Est_4W is +0.48% over the entry (+0.23 ATR), which is SE-2 territory: a flat forward horizon on an otherwise-bullish ETF print, to be treated as a <=4-week tactical swing at best and not worth the slot. Same 0.53-ATR family stop and same -2 FailedBreakdown haircut as XBI, and the same single-print flip out of three NO TRADE cv0 prints. Between the two biotech vehicles XBI is the better expression and it was itself declined. RE-ARM: only if Est_4W lifts meaningfully above the close with the stop widening past 1.0 ATR.
Health Care Select Sector SPDRNO ACTIONn/an/an/aBelow the floor at 64 adjusted, and the forward view is dead anyway. Raw 66 minus the -2 FailedBreakdown haircut lands one point short of 65, and Est_12W sits 2.0% BELOW the close while Est_4W is +0.09% -- SE-2 fires on both legs. Healthcare was genuinely bid (+0.66% on a red tape) and the trail is stable (BUY -> 66), but the stop is 0.50 ATR and the payoff 0.13x. RE-ARM: needs Est_12W positive versus the close AND conviction at 65+.
Destiny Tech100 IncNO ACTIONn/an/an/aBlocked by the hard quality gate -- Quality_Pass = False (F-Score/FCF screen failed), which blocks new entries outright. It is the only non-ETF row with a valuation read: OVERVALUED_VS_RI, MoS_FV -0.78 -> val_adj -4, taking. That valuation is 83 days stale (FetchedAt 2026-06-11, price marked vs today's), so the gate is applied with a staleness caveat -- but a PullbackBuy on a -1.65% session in a closed-end vehicle trading 57% below its 52-week high, with a /sh (8.6%) stop, is not a slot contest we need to enter. Also the entry sits ABOVE the close.
Technology Select Sector SPDRNO ACTIONn/an/an/aWATCH 63, not in the buy pool. Fell -1.53% on the yield shock; close is now BELOW EMA20 for the first time in the window. Ranging regime, RSI 49.8, Portion 0.
Financial Select Sector SPDRNO ACTIONn/an/an/aWATCH 54 after a four-session slide BUY -> 67 -> WATCH 54, and it closed -0.88% despite rising yields. Entry is 1.24 ATR ABOVE the close, so the print is not actionable. The 08-28 re-arm (Est_12W back above Est_4W with conviction >=70) is not met: Est_12W < Est_4W.
Consumer Staples Select Sector SPDRNO ACTIONn/an/an/aWATCH 54, +0.32% -- defensive bid intact but Est_4W is BELOW the close. Nothing to act on.
SPDR S&P 500 ETFNO ACTIONn/an/an/aWATCH 35 -- a 40-point conviction collapse over four sessions (BUY -> WATCH as the index fell -0.69% through EMA20. The book-wide read: this is a risk-off tape, not a dip.
Invesco QQQ (Nasdaq-100)NO ACTIONn/an/an/aWATCH 52, -1.27%, closed below EMA20 and EMA50. Est_12W is still +8.2% but the near-term tape is the rate shock. The 08-28 re-arm (a green close holding above EMA20) is not met.
SPDR Dow Jones Industrial AvgNO ACTIONn/an/an/aWATCH 35, -0.72%, below EMA20 and EMA50. The Dow fell 374 points.
Consumer Discretionary Select Sector SPDRNO ACTIONn/an/an/aFlipped to AVOID 52 on a RallySell_BearTrend print after -1.72%; RSI 42.5 and price below EMA20, EMA50 and EMA200 simultaneously. Long-only, so no action, but the 08-28 'watch whether the cyclical rotation has legs' question is answered: it did not.
Procure Space ETFNO ACTIONn/an/an/aAVOID 28 -- the board's weakest name for a fifth session, -1.99%, RSI 32.3, below EMA20/50/200. Long-only, no action.
VanEck Semiconductor ETFNO ACTIONn/an/an/aNO TRADE cv0, -2.05%. The semiconductor read is now blind for a SIXTH consecutive session (see systemic finding 3) and AVGO reports after the close on 09-02.
iShares Semiconductor ETFNO ACTIONn/an/an/aNO TRADE cv0, -2.10%, eighth consecutive cv0 print. Same blindness as SMH.
Global X Artificial Intelligence & Technology ETFNO ACTIONn/an/an/aNO TRADE cv0, -1.93%; collapsed STRONG BUY 85 -> WATCH 62 -> BUY 67 -> NO TRADE 0 over four sessions. The 08-27 no-chase decline is now vindicated twice over.
Defiance Quantum ETFNO ACTIONn/an/an/aNO TRADE cv0, -2.28% -- long-duration speculative growth taking the yield shock hardest.
SPDR Gold SharesNO ACTIONn/an/an/aNO TRADE cv0 and -2.86%, a second heavy down session. Notable: gold FELL on a day of US airstrikes on Iran, which says the bond sell-off and the real-rate move dominated the geopolitical bid. The 08-08 decline streak now stands at roughly -0.4% versus the entry reference -- the cost of that decline has fully closed.
iShares Russell 2000 ETFNO ACTIONn/an/an/aNO TRADE cv0, -1.14%, RSI 38.4 and below EMA20/50. Small caps take the yield shock directly.
Industrial Select Sector SPDRNO ACTIONn/an/an/aNO TRADE cv0, -1.37%, RSI 30.4 -- the most oversold name on the board and 4.2% below EMA20. Watch for a washout print, but the engine sees nothing.

Outcome & track record

Accuracy at the time of this record.

37 Graded decisions Past recommendations old enough to score against what actually happened (target hit / stopped out / closed). This is the evidence base — the bigger the number, the more history behind the calls. Click to inspect every one. See the decisions →
-0.080 1-week calibration How much of the eventual 4-week move typically shows up in the first week (0 = almost none, 1 = most of it). Use it to read the 1-week estimates: a low number means prices drift toward the target slowly, so don't over-read a soft week-1.
50 Published records How many dated end-of-day verdicts exist for this book — the length of the public track record you can browse in the Archive below.

This website is for educational purposes only and does not constitute investment advice. Always do your own research and assess your own risk tolerance before making investment decisions.